Hong‐Van Tieu

机构：NewYork–Presbyterian Hospital, New York Blood Center, Columbia University Irving Medical Center · ORCID：0000-0002-7880-6448

发表论文 110 篇 · 总被引 2461 次 · h-index 29

代表论文

• Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial (2025 · Science Translational Medicine · 被引 44)
• High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302) (2025 · Annals of Internal Medicine · 被引 13)
• An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals (2024 · medRxiv · 被引 8)
• Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial (2024 · EBioMedicine · 被引 7)
• Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data (2025 · JAMA Network Open · 被引 6)
• SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals (2024 · JAMA Network Open · 被引 6)